189 related articles for article (PubMed ID: 8590578)
1. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.
Di Braccio M; Roma G; Leoncini G; Poggi M
Farmaco; 1995 Oct; 50(10):703-11. PubMed ID: 8590578
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
3. 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation.
Di Braccio M; Roma G; Grossi GC; Leoncini G; Maresca M
Farmaco; 1992 Jan; 47(1):77-90. PubMed ID: 1616579
[TBL] [Abstract][Full Text] [Related]
4. 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
Roma G; Di Braccio M; Leoncini G; Aprile B
Farmaco; 1993 Sep; 48(9):1225-38. PubMed ID: 8259980
[TBL] [Abstract][Full Text] [Related]
5. Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis.
Roma G; Braccio MD; Carrieri A; Grossi G; Leoncini G; Grazia Signorello M; Carotti A
Bioorg Med Chem; 2003 Jan; 11(1):123-38. PubMed ID: 12467715
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
[TBL] [Abstract][Full Text] [Related]
7. Ethyl or methyl 6-substituted 3-(benzoylamino)-2-oxo-2H-pyran-5-carboxylates and 3-(benzoylamino)-7,8-dihydro-2H-1-benzopyran-2,5(6H)-diones with local anesthetic, platelet antiaggregating and other activities.
Mosti L; Menozzi G; Schenone P; D'Amico M; Falciani M; Rossi F
Farmaco; 1994 Jan; 49(1):45-50. PubMed ID: 8185749
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
10. Benzo[6,7]cyclohepta[1,2-b]pyran derivatives with platelet antiaggregating and other activities.
Bargagna A; Longobardi M; Mariani E; Schenone P; Cenicola ML; Losasso C; Carnevale M; Marmo E
Farmaco; 1991 Mar; 46(3):461-75. PubMed ID: 1892503
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of coumarin alpha-methylene-gamma-butyrolactones: a new class of platelet aggregation inhibitors.
Chen YL; Wang TC; Liang SC; Teng CM; Tzeng CC
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1591-5. PubMed ID: 8795278
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
Yao FM; Sun CS
Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
[TBL] [Abstract][Full Text] [Related]
14. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
15. Thieno[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2-dihydrogenated homologues: synthesis, enhanced in vitro antiaggregant activity for reduced compounds.
Gravier D; Hou G; Casadebaig F; Dupin JP; Bernard H; Boisseau M
Pharmazie; 1992 Oct; 47(10):754-7. PubMed ID: 1480651
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Ferreira VF; Lima ES; de Souza MC; Carlos EC; Castro HC; Geraldo RB; Rodrigues CR; Almeida MC; Cunha AC
Bioorg Med Chem; 2009 May; 17(10):3713-9. PubMed ID: 19380229
[TBL] [Abstract][Full Text] [Related]
19. Two new coumarin derivatives from the roots of Heracleum rapula.
Niu XM; Li SH; Wu LX; Li L; Gao LH; Sun HD
Planta Med; 2004 Jun; 70(6):578-81. PubMed ID: 15229811
[TBL] [Abstract][Full Text] [Related]
20. Feroniellin B, a new highly potent human platelet aggregation inhibitor from Feroniella lucida.
Phuwapraisirisan P; Surapinit S; Jeenapongsa R; Tip-pyang S; Kokpol U
Phytother Res; 2007 May; 21(5):485-7. PubMed ID: 17245685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
